Contract facts
NONE8509437711!TASK ORDER 2 is a federal NONE award for Dcso Philadelphia held by Epigen Technology Corp. Estimated value $3.6M ($3.6M obligated). Current period of performance ends Sep 29, 2023. Last award drew 2 bidders. Related solicitation SP470121Q9001.
Recompete timing
PublicCurrent PoP ended Sep 29, 2023 (1057 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract SP470122F0216?
SP470122F0216 (8509437711!task ORDER 2) is a Dcso Philadelphia award with a potential value of $3.6M, currently held by Epigen Technology Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is SP4701-22-F-0216?
SP4701-22-F-0216 is the dashed form of PIID SP470122F0216 (8509437711!task ORDER 2), held by Epigen Technology Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded SP470122F0216?
Dcso Philadelphia awarded SP470122F0216 to Epigen Technology Corp (potential $3.6M).
Who is the incumbent on SP470122F0216?
Epigen Technology Corp is the incumbent. The current period of performance ends Sep 29, 2023.
When does Epigen Technology Corp’s SP470122F0216 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 29, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.